1. Home
  2. Author
  3. Rothe M

Rothe M

References (2)

Title : Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma - Leineweber_2023_Front.Pharmacol_14_1124214
Author(s) : Leineweber CG , Rabehl M , Pietzner A , Rohwer N , Rothe M , Pech M , Sangro B , Sharma R , Verslype C , Basu B , Sengel C , Ricke J , Schebb NH , Weylandt KH , Benckert J
Ref : Front Pharmacol , 14 :1124214 , 2023
Abstract : Leineweber_2023_Front.Pharmacol_14_1124214
ESTHER : Leineweber_2023_Front.Pharmacol_14_1124214
PubMedSearch : Leineweber_2023_Front.Pharmacol_14_1124214
PubMedID: 36937889

Title : Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase - Boldt_2016_Am.J.Physiol.Renal.Physiol_311_F1198
Author(s) : Boldt C , Roeschel T , Himmerkus N , Plain A , Bleich M , Labes R , Blum M , Krause H , Magheli A , Giesecke T , Mutig K , Rothe M , Weldon SM , Dragun D , Schunck WH , Bachmann S , Paliege A
Ref : American Journal of Physiology Renal Physiol , :ajprenal 00062 2016 , 2016
Abstract : Boldt_2016_Am.J.Physiol.Renal.Physiol_311_F1198
ESTHER : Boldt_2016_Am.J.Physiol.Renal.Physiol_311_F1198
PubMedSearch : Boldt_2016_Am.J.Physiol.Renal.Physiol_311_F1198
PubMedID: 27681558